Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP71529.RAbVg5UIBAjXq6bdiXMa3ALcZjIRLmYI-xyKt1UcEwjxo130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71529.RAbVg5UIBAjXq6bdiXMa3ALcZjIRLmYI-xyKt1UcEwjxo130_provenance.
• assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP331709.RAcI8GuoXrb6AVwF39cRF0sfl6U3JM-m9oN3m8I6IwgYo130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331709.RAcI8GuoXrb6AVwF39cRF0sfl6U3JM-m9oN3m8I6IwgYo130_provenance.
• NP334690.RAoeX5vSRTeJooizRHg1g8svkTSlz39xmOvAkZuXI0GX4130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334690.RAoeX5vSRTeJooizRHg1g8svkTSlz39xmOvAkZuXI0GX4130_provenance.
• NP76899.RAkXMrZYhF2Gw-TVgYrOk3OsfoCUg4lFu3EPttj_1fwF0130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76899.RAkXMrZYhF2Gw-TVgYrOk3OsfoCUg4lFu3EPttj_1fwF0130_provenance.
• NP261562.RAsTB0tQdBqDIcGHDqIbZb0jzmirNgDwEBZvKE1b_L-lg130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261562.RAsTB0tQdBqDIcGHDqIbZb0jzmirNgDwEBZvKE1b_L-lg130_provenance.
• NP723207.RAvL3HWcdoKJjA3OpiFKhBmc9xYunyGJBMQa1pGFygPT8130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723207.RAvL3HWcdoKJjA3OpiFKhBmc9xYunyGJBMQa1pGFygPT8130_provenance.
• assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP113076.RAhhXlQlenCKkq-mr-JgS-KsqG1DAu5DGoBfu6gUM4ZRg130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113076.RAhhXlQlenCKkq-mr-JgS-KsqG1DAu5DGoBfu6gUM4ZRg130_provenance.
• NP97350.RAjemHTVkfX6D8qJzk61zu46hOBXS6eKq6oBJz0zG1XsY130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97350.RAjemHTVkfX6D8qJzk61zu46hOBXS6eKq6oBJz0zG1XsY130_provenance.
• NP778440.RAWKy-nkLHkj6IVuMoWiANQ6Qy7VgShHZ_cBxzi7-aems130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778440.RAWKy-nkLHkj6IVuMoWiANQ6Qy7VgShHZ_cBxzi7-aems130_provenance.
• NP160669.RAoRdqhjrSdn38wShzO9sRgxVAhtXwF1P7Fu2VQzPqLeA130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160669.RAoRdqhjrSdn38wShzO9sRgxVAhtXwF1P7Fu2VQzPqLeA130_provenance.
• NP228664.RAIpTV3zC2dpJFuue5Ej5rkSw6zgfL_m4FPCEPyOggI6E130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228664.RAIpTV3zC2dpJFuue5Ej5rkSw6zgfL_m4FPCEPyOggI6E130_provenance.
• NP334051.RANeSjanmEIX27b3pO8qcH-sKCrpG38iLKYS6eW0gmOWw130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334051.RANeSjanmEIX27b3pO8qcH-sKCrpG38iLKYS6eW0gmOWw130_provenance.
• NP334060.RAFh4MwO9RWIcpIj7SFkgF4zsW4JFg8AYorTaRuplbCYU130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334060.RAFh4MwO9RWIcpIj7SFkgF4zsW4JFg8AYorTaRuplbCYU130_provenance.
• NP778436.RAOYEdbpJ5b5sYr-RSa_OZSqv-rtAQjBLUddjDaSxQlKQ130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778436.RAOYEdbpJ5b5sYr-RSa_OZSqv-rtAQjBLUddjDaSxQlKQ130_provenance.
• NP778437.RAzyZI63x4Of69l6IJh6SBmnd7QP14-i34Q9XbmT6t9v8130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778437.RAzyZI63x4Of69l6IJh6SBmnd7QP14-i34Q9XbmT6t9v8130_provenance.
• NP778439.RAz9SmoNuo-6Bebkx5wFDpRx0_3bXxHacrQglkvpuZvus130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778439.RAz9SmoNuo-6Bebkx5wFDpRx0_3bXxHacrQglkvpuZvus130_provenance.
• NP160668.RA_bpSzvRDHEZw-WvubNHMsjuXoDnOT4c3MUoLHyVsx3c130_assertion description "[Mutations in JAG1 were detected in three patients with Alagille syndrome (1.3%), while NKX2.5 mutations were seen in two patients with non-syndromic ToF (0.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160668.RA_bpSzvRDHEZw-WvubNHMsjuXoDnOT4c3MUoLHyVsx3c130_provenance.